Einar Baldvin Árnason
- Banking and Finance
- Commercial and Company Law
- Competition Law
- Mergers and Acquisitions
- Administrative Law
- Corporate Restructuring
- Bankruptcy and Insolvency
- University of Wisconsin - Madison, M.L.I. (Master of Legal Institutions) 2007
- District Court Attorney, 2000
- University of Iceland, Cand. jr. 1999
Takeover bid of all shares issued by Heimavellir hf.
BBA//Fjeldco provided legal counsel in respect to the takeover bid process with all shares issued by Heimavellir hf.
The transaction was structured as an initial stake building to trigger a mandatory takeover offer. This was the first transaction in Iceland for numerous years whereas a mandatory takeover offer has been triggered with the intent of the offeror to acquire the target.
With the bidder being a Norwegian entity BBA//Fjeldco provided legal counsel on Icelandic law issues relating to all securities transactions, the takeover bid and the takeover process.
Alvotech hf. and Icelandic biopharmaceutical
BBA//Fjeldco acted as legal advisor to Alvotech hf., an Icelandic biopharmaceutical company focused on the development and manufacturing of high quality biosimilars for global markets, during the restructuring of Alvotechhf. BBA also advised on the issuance of USD 300,000,000 convertible bond, issued by Alvotech Holding A.S., whereas Alvotech hf., Glycothera GMBH, AlvotechGermany GMBH and Alvotech Swiss AG acted as guarantors.
BBA//Fjeldco advised Festi hf. in relation to the acquisition of Kaupás ehf. and other subsidiaries of Norvik hf. Although the value of the agreement is confidential, it is safe to say that the deal is one of the largest domestic M&A deals in recent years.
Aquisition of Lyfja
BBA//Fjeldco advised Stefnir hf., Iceland’s largest fundmanagement company on all aspects in relation to one of its fund’s acquisition of Iceland's leading pharmacy retail company Lyfja.
BBA acted as a legal advisor to Alvotech hf., and Icelandic biopharmaceutical company focused on the development and manufacturing of high quality biosimilars for global markets, during the restructuring of Alvotech hf. BBA also advised on the issuance of USD 300,000,000 by Alvotech Holding A.S. whereas Alvotech hf., Glycothera GMBH, Alvotech Germany GMBH and Alvotech Swiss AG acted as guarantors.
BBA//Fjeldco advised Stefnir hf., Iceland’s largest fund management company, on all aspects in relation to one of its fund’s acquisition of one of Iceland´s leading metalwork companies.
BBA//Fjeldco was a legal adviser to Stefnir hf. in relation to its acquisition of equity in Verne Global (a data center).